NUVL vs OGN · $5.81B cap vs P/E 3.4, rev $3.02B
Nuvalent Inc (NUVL) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Nuvalent Inc (NUVL) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
NUVL does not have a complete income-statement cache yet.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
NUVL currently screens at market cap $5.81B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the NUVL and OGN stock pages for the full models.
Not investment advice.